Children awaiting heart transplant survive longer with VADs than ECMO
from Cardiovascular Business
Ventricular assist devices (VADs) foster improved survival for children awaiting heart transplantation when compared to the current standard of extracorporeal membrane oxygenation (ECMO), according to a new study in the Journal of the American College of Cardiology. When 164 pediatric patients were matched one-to-one to eliminate differences in baseline characteristics, those treated with VADs alone were twice as likely to survive from waitlist to transplant and survived an average of 39 percent longer versus patients treated with ECMO alone.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063